ConductScience.org, home

Paper75740

Studies with bleomycin and misonidazole on aerated and hypoxic cells.

Roizin-Towle L and 1 other. Br J Cancer, 1978. Cited by 72 papers, by iCite.

Cite this record

ConductScience Library. Studies with bleomycin and misonidazole on aerated and hypoxic cells. Papers, record 75740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75740

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Studies with bleomycin and misonidazole on aerated and hypoxic cells.
PubMed
Journal
Br J Cancer
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
1.81
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roizin-Towle LL
2Hall EJE J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
Cell SurvivalMajor topic
NitroimidazolesMajor topic
OxygenMajor topic
Cell Line
Dose-Response Relationship, Drug
Hypoxia
Temperature

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11178881Hypoxic sensitizers: radiobiological studies at the cellular level.Radiology1975https://conductscience.org/library/papers/1178881PubMed
24107188The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro.Cancer Res1971https://conductscience.org/library/papers/4107188PubMed
34121931Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.J Natl Cancer Inst1973https://conductscience.org/library/papers/4121931PubMed
44122362A clinical review of bleomycin--a new antineoplastic agent.Cancer1973https://conductscience.org/library/papers/4122362PubMed
54128424Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents.Cancer Chemother Rep1973https://conductscience.org/library/papers/4128424PubMed
64131156Effects of bleomycin on progression through the cell cycle of mouse L-cells.Cancer Res1974https://conductscience.org/library/papers/4131156PubMed
74451633Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.Br J Cancer1974https://conductscience.org/library/papers/4451633PubMed
84598448Chemical radiosensitization of hypoxic cells.Br Med Bull1973https://conductscience.org/library/papers/4598448PubMed
948253Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/48253PubMed
104853356Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells.Cancer Chemother Rep1974https://conductscience.org/library/papers/4853356PubMed
114858160Split-dose experiments with hypoxic cells. Implications for fractionated and low-dose-rate radiotherapy.Radiology1974https://conductscience.org/library/papers/4858160PubMed
1252401Enhanced cell killing by bleomycin and 43 degrees hyperthermia and the inhibition of recovery from potentially lethal damage.Cancer Res1975https://conductscience.org/library/papers/52401PubMed
135525541Combination chemotherapy in the treatment of advanced Hodgkin's disease.Ann Intern Med1970https://conductscience.org/library/papers/5525541PubMed
1458718The significance of DNA damage in the cell cycle sensitivity of Chinese hamster ovary cells to bleomycin.Cancer Res1976https://conductscience.org/library/papers/58718PubMed
155953301New antibiotics, bleomycin A and B.J Antibiot (Tokyo)1966https://conductscience.org/library/papers/5953301PubMed
1663956Action of bleomycin on experimental tumours.Prog Biochem Pharmacol1976https://conductscience.org/library/papers/63956PubMed
1763972Effect of bleomycin on cell survival and some implications for tumor therapy.Prog Biochem Pharmacol1976https://conductscience.org/library/papers/63972PubMed
18856238Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.Br J Cancer1977https://conductscience.org/library/papers/856238PubMed
19885756Ro-07-0582 as a radiosensitizer and cytotoxic agent.Int J Radiat Oncol Biol Phys1977https://conductscience.org/library/papers/885756PubMed

Download CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
34506737The importance of understanding the infectious microenvironment.Lancet Infect Dis2022https://conductscience.org/library/papers/34506737PubMed
26282406Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours.BMC Vet Res2015https://conductscience.org/library/papers/26282406PubMed
26251616Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer.Onco Targets Ther2015https://conductscience.org/library/papers/26251616PubMed
23007796The relationship between tissue oxygenation and redox status using magnetic resonance imaging.Int J Oncol2012https://conductscience.org/library/papers/23007796PubMed
7923551Modulation of tumor cell response to chemotherapy by the organ environment.Cancer Metastasis Rev1994https://conductscience.org/library/papers/7923551PubMed
7470389Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions.Br J Cancer1981https://conductscience.org/library/papers/7470389PubMed
7459244In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.Br J Cancer1981https://conductscience.org/library/papers/7459244PubMed
7459222Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.Br J Cancer1980https://conductscience.org/library/papers/7459222PubMed
7437289Cytotoxicity of adriamycin on aerobic and hypoxic chinese hamster V79 cells in vitro.Br J Cancer1980https://conductscience.org/library/papers/7437289PubMed
7272187Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.Br J Cancer1981https://conductscience.org/library/papers/7272187PubMed
7248157Enhancement of the effect of cytotoxic drugs by radiosensitizers.Br J Cancer1981https://conductscience.org/library/papers/7248157PubMed
7190019Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.Br J Cancer1980https://conductscience.org/library/papers/7190019PubMed
6540780Sectional analysis of tumor colony growth in the soft-agar assay: effects of oxygen.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6540780PubMed
6466544Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.Br J Cancer1984https://conductscience.org/library/papers/6466544PubMed
6212075Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.Br J Cancer1982https://conductscience.org/library/papers/6212075PubMed
6187010Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6187010PubMed
6177286Modulation of bleomycin cytotoxicity.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6177286PubMed
6175649Differential survival of cell subpopulations in spheroids after treatment with bleomycin.J Cancer Res Clin Oncol1981https://conductscience.org/library/papers/6175649PubMed
6168277Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.Br J Cancer1981https://conductscience.org/library/papers/6168277PubMed
3801287Oxygen dependence for chemosensitization by misonidazole.Br J Cancer1986https://conductscience.org/library/papers/3801287PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/75740

GET https://conductscience.org/api/papers/v1/75740/cited_by?page=2